Target intelligence / Profile preview

Multiple endogenous mRNAs with miR-216a seed matches

Molecular classification
Messenger RNA, Nucleic acid
01

Overview

Multiple endogenous mRNAs with miR-216a seed matches refers to the collective ensemble of messenger RNA (mRNA) transcripts that are post-transcriptionally regulated by microRNA-216a (miR-216a). miR-216a is a highly conserved, pancreas-specific microRNA that plays a critical role in maintaining cellular homeostasis and modulating signaling pathways by binding to complementary seed sequences in the 3' untranslated regions (UTRs) of target mRNAs (PubMed: 21835060). This binding typically results in the degradation of the mRNA or the inhibition of its translation into protein via the RNA-induced silencing complex (RISC). Key validated targets within this group include PTEN, which regulates the PI3K/Akt pathway, and SMAD7, a negative regulator of TGF-beta signaling (PubMed: 25135801, PubMed: 24631445). In diseases such as pancreatic cancer, miR-216a often acts as a tumor suppressor by targeting oncogenes like YBX1, whereas in kidney disease, its upregulation can contribute to fibrosis by silencing protective factors. Therapeutic strategies involve using miR-216a mimics to restore its suppressive function in cancer or antagomirs to block its activity in fibrotic conditions. Consequently, this target represents a complex regulatory network rather than a single molecular entity.

Other names
miR-216a targetomemiR-216a-5p target genesmiR-216a-3p target genesMicroRNA-216a regulated transcripts
02

Mechanism of action

MicroRNA-mediated gene silencing via seed-sequence complementarity to the 3' UTR of target mRNAs, leading to mRNA cleavage or translational inhibition.

03

Biological functions

Post-transcriptional gene regulationmRNA degradationTranslational repressionCell proliferationApoptosis
04

Disease associations

Pancreatic cancerRenal fibrosisHepatocellular carcinomaAcute pancreatitisChronic kidney disease
05

Safety considerations

Off-target silencing of non-intended mRNAsSaturation of the RISC complexPotential for systemic toxicity with lipid nanoparticle deliveryTissue-specific over-suppression of essential pathways
06

Interacting drugs

miR-216a mimic

2 more in the full profile.

07

Biomarkers

miR-216a expression levelsPTEN protein levelsSMAD7 protein levelsYBX1 protein levels

Beyond the preview

Go deeper on Multiple endogenous mRNAs with miR-216a seed matches.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple endogenous mRNAs with miR-216a seed matches.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call